AY
Aytu BioPharma, Inc.
AYTU · NASDAQ
$2.19 -1.35% (-$0.03)
1M -7.98%
Market Cap $24.5M
P/E Ratio -
Div. Yield -
ROE 148.91%
Piotroski F-Score Weak
3/9Valuation
93 /100
Cheap P/FCF 14.92x
P/S 0.43x
P/B 0.70x
Growth
0 /100
Declining Book val. growth 24.64%
Rev. growth 11.78%
FCF growth N/A
Profitability
27 /100
Weak Op. margin 26.79%
Gross margin 62.50%
FCF margin 2.90%
Quality
6 /100
Poor ROA 30.49%
ROIC 23.93%
Asset turnover 0.51x
Debt
44 /100
Moderate Int. coverage -14.02x
Debt/Equity 0.65x
Current ratio 1.12x
Stability
33 /100
Unstable EPS volatility 35.35%
Beta 0.26x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AYTU
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Joshua R. Disbrow
Employees
83
Headquarters
Denver
Evenimente viitoare
22 SEPT.
Earnings
Upcoming earnings report
29 SEPT.
Earnings
Upcoming earnings report